Bionano Genomics Inc. Set to Release Quarterly Earnings Report

Bionano Genomics, Inc., a prominent player in the health care sector, specifically within the life sciences tools and services industry, is preparing to release its quarterly earnings report. The company, headquartered in San Diego, United States, is known for its innovative platform that analyzes long segments of genomic DNA and other biomolecules’ structural variations. This is achieved through their proprietary nanochannel chips, automated imaging instruments, integrated software, and application-specific reagents.

The company’s stock has experienced significant fluctuations over the past year. It reached a 52-week high of $72.6 USD on May 14, 2024, and a low of $2.68 USD on March 30, 2025. As of May 8, 2025, the stock closed at $3.8355 USD. This closing price reflects the company’s current market value and highlights the volatility in its stock performance.

Bionano Genomics is listed on the Nasdaq stock exchange and has a market capitalization of approximately $11,475,291 USD. The company went public with its initial public offering on August 21, 2018. For more detailed information about their offerings and initiatives, interested parties can visit their website at www.bionanogenomics.com .

As the company anticipates the release of its quarterly earnings report, stakeholders and investors are keenly observing the potential impact on its stock price and overall market position.